Pages that link to "Q39507740"
Jump to navigation
Jump to search
The following pages link to Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis (Q39507740):
Displaying 44 items.
- Mifepristone for uterine fibroids (Q24201506) (← links)
- Mifepristone for uterine fibroids (Q24241937) (← links)
- Corticosteroids and cognition (Q28207453) (← links)
- Estradiol and progesterone-induced slowing of gonadotropin-releasing hormone pulse frequency is not reversed by subsequent administration of mifepristone (Q30434638) (← links)
- RU 486 (mifepristone) (Q33560317) (← links)
- Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486 (Q33921299) (← links)
- Antioxidant: a new role for RU-486 and related compounds (Q34157921) (← links)
- Antiprogestins in gynecological diseases (Q34587636) (← links)
- A benefit-risk assessment of medical treatment for uterine leiomyomas (Q34836796) (← links)
- Medical management of endometriosis-associated pain (Q35108932) (← links)
- Mifepristone. Separating fact from fiction (Q35156210) (← links)
- The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells (Q36672641) (← links)
- Endometriosis: medical therapy (Q39489532) (← links)
- CDB-4124, a Progesterone Receptor Modulator, Inhibits Mammary Carcinogenesis by Suppressing Cell Proliferation and Inducing Apoptosis (Q39625598) (← links)
- Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential (Q40486441) (← links)
- Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486). (Q40851559) (← links)
- Mifepristone (RU486): a review (Q40873818) (← links)
- Modern medical management of endometriosis (Q40894046) (← links)
- The effect of RU 486 and related compounds on cultured macrophage differentiation and function (Q41180482) (← links)
- Endometriosis--a disease because it is characterized by bleeding (Q41378452) (← links)
- Vulnerability of the Endocrine System to Xenobiotic Influence (Q41618252) (← links)
- After levonorgestrel, will mifepristone (RU486) be the next day-after pill? (Q43595616) (← links)
- Synthesis and progesterone receptor antagonist activities of 6-aryl benzimidazolones and benzothiazolones (Q43759919) (← links)
- Potent nonsteroidal progesterone receptor agonists: synthesis and SAR study of 6-aryl benzoxazines (Q43891625) (← links)
- Effect of mifepristone on estrogen and progesterone receptors in human endometrial and endometriotic cells in vitro (Q43992069) (← links)
- New progesterone receptor antagonists: 3,3-disubstituted-5-aryloxindoles (Q44207206) (← links)
- Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential. (Q44458208) (← links)
- Present and potential uses of mifepristone in gynecology, obstetrics and other medical specialties (Q45248905) (← links)
- An open label trial of C-1073 (mifepristone) for psychotic major depression (Q46152690) (← links)
- The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study. (Q46204250) (← links)
- Clinical Pharmacokinetics of Mifepristone (Q55969259) (← links)
- Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies (Q58606179) (← links)
- Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception (Q70494744) (← links)
- Time-related effects of RU486 treatment in experimentally induced endometriosis in the rat (Q70542180) (← links)
- Morphology of the rat uterus after long-term treatment with progesterone antagonists (Q70705357) (← links)
- Inhibition of oxidative modification of proteins by RU486 (Q71383441) (← links)
- An exchange of ideas and "boutades" (Q71556328) (← links)
- Progesterone antagonist RU 486 has bone-sparing effects in ovariectomized rats (Q71784284) (← links)
- Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth (Q71808446) (← links)
- Endometrial effects of long-term low-dose administration of RU486 (Q72629934) (← links)
- Alterations in the pituitary-thyroid and pituitary-adrenal axes--consequences of long-term mifepristone treatment (Q73119589) (← links)
- Chronic antiprogestin therapy produces a stable atrophic endometrium with decreased fibroblast growth factor: a 1-year primate study on contraception and amenorrhea (Q74561304) (← links)
- Regulation of monocyte to macrophage differentiation by antiglucocorticoids and antioxidants (Q77221594) (← links)
- Mifepristone Treatment in Pregnant Murine Model Induced Mammary Gland Dysplasia and Postpartum Hypogalactia (Q90181996) (← links)